Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes. | JCO Precis Oncol | 2025 | 40632975 | PubTator, text mining | PubMed |
| Fractionation of water-soluble organic matter (WSOM) with polyvinylpyrrolidone: A study on antimony associated with WSOM in contaminated soils. | J Environ Sci (China) | 2025 | 40602883 | PubTator, text mining | PubMed |
| The effect of transcranial direct current stimulation on frontal alpha asymmetry and visuospatial attention in food-reward contexts: a triple-blind randomized sham-controlled study. | BMC Psychol | 2025 | 40598654 | PubTator, text mining | PubMed |
| Identifying CDCA4 as a Radiotherapy Resistance-Associated Gene in Colorectal Cancer by an Integrated Bioinformatics Analysis Approach. | Genes (Basel) | 2025 | 40565588 | PubTator, text mining | PubMed |
| miR-29a-3p and TGF-β Axis in Fanconi anemia: mechanisms driving metabolic dysfunction and genome stability. | Cell Mol Life Sci | 2025 | 40555815 | PubTator, text mining | PubMed |
| Development of translational read-through-inducing drugs as novel therapeutic options for patients with Fanconi anemia. | Cell Death Discov | 2025 | 40544182 | PubTator, text mining | PubMed |
| ALDH9A1 deficiency as a source of endogenous DNA damage that requires repair by the Fanconi anemia pathway. | J Cell Biol | 2025 | 40540243 | PubTator, text mining | PubMed |
| A lasting impression. | Elife | 2025 | 40511665 | PubTator, text mining | PubMed |
| Evolution of the Neoproterozoic Kareim Basin, north Arabian - Nubian shield. | Sci Rep | 2025 | 40394055 | PubTator, text mining | PubMed |
| Critical role of alpha spectrin in DNA repair: the importance of μ-calpain and Fanconi anemia proteins. | Exp Biol Med (Maywood) | 2025 | 40375875 | PubTator, text mining | PubMed |
| Clinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome. | Ann Hematol | 2025 | 40358701 | PubTator, text mining | PubMed |
| Case Report: Two cases of chemotherapy refractory aggressive variant prostate cancer with extreme durable response to PARP inhibitor. | Front Oncol | 2025 | 40342821 | PubTator, text mining | PubMed |
| A novel splicing graph allows a direct comparison between exon-based and splice junction-based approaches to alternative splicing detection. | Brief Bioinform | 2025 | 40341920 | PubTator, text mining | PubMed |
| Germinal mutations among patients with breast cancer in Colombia: is BRCA3 coming? | Ecancermedicalscience | 2025 | 40259910 | PubTator, text mining | PubMed |
| Deficiency of the Fanconi anemia core complex protein FAAP100 results in severe Fanconi anemia. | J Clin Invest | 2025 | 40244696 | PubTator, text mining | PubMed |
| Firing properties of muscle spindle afferents in the intrinsic foot muscles and tactile afferents from the sole of the foot during upright stance. | Exp Physiol | 2025 | 40211475 | PubTator, text mining | PubMed |
| The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivo. | BMC Cancer | 2025 | 40119293 | PubTator, text mining | PubMed |
| PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia. | Cancer Res Commun | 2025 | 40111122 | PubTator, text mining | PubMed |
| Case Report: Complete response to four cycles of camrelizumab in a PD-L1 negative patient with advanced oral squamous cancer. | Front Immunol | 2025 | 40066447 | PubTator, text mining | PubMed |
| Mutations in Anaplastic Thyroid Carcinoma: An Analysis of the Japanese National Genomic Database. | Laryngoscope Investig Otolaryngol | 2025 | 40061205 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=7